中药保留灌肠治疗女性盆腔炎的临床及 基础研究进展
Clinical and Basic Research Progress of Traditional Chinese Medicine Retention Enema in the Treatment of Female Pelvic Inflammatory Disease
摘要: 慢性盆腔炎是困扰育龄期女性的常见慢性炎症性疾病,以病程迁延、反复发作、易致盆腔粘连和不孕为特点,临床治疗棘手。中药保留灌肠作为中医特色外治法之一,凭借“药达病所、避开头过”的独特优势,在该病治疗中展现出卓越潜力。本文系统梳理了中药保留灌肠治疗慢性盆腔炎的临床应用现状,并从现代药理学角度深入阐释其抗炎、免疫调节、改善微循环、抗纤维化及调节肠道微生态等多靶点作用机制,同时基于“肺与大肠相表里”理论探讨直肠给药与全身气血调节的内在联系,最后分析了该疗法的剂型革新、技术优化与未来研究方向,以期为该疗法的临床推广与深入研究提供理论依据。
Abstract: Chronic pelvic inflammatory disease (CPID) is a common chronic inflammatory condition affecting women of reproductive age, characterized by a protracted course, recurrent episodes, and a high propensity to cause pelvic adhesions and infertility, posing significant clinical challenges. Traditional Chinese medicine (TCM) retention enema, as a distinctive external therapy of TCM, has demonstrated remarkable potential in treating CPID by virtue of its unique advantage of “delivering medicine directly to the affected site while bypassing hepatic first-pass metabolism”. This article systematically reviews the current clinical application status of TCM retention enema in treating CPID, and provides an in-depth elucidation of its multi-target mechanisms from the perspective of modern pharmacology, including anti-inflammatory effects, immunomodulation, improvement of microcirculation, anti-fibrosis, and regulation of the intestinal microecology. Furthermore, based on the TCM theory of “the lung and large intestine being interior-exteriorly related”, this paper explores the intrinsic connection between rectal administration and systemic regulation of Qi and blood. Finally, it analyzes the innovations in dosage forms, technological optimization, and future research directions of this therapy, aiming to provide a theoretical foundation for its clinical promotion and further investigation.
文章引用:黄泸玉, 丛慧芳. 中药保留灌肠治疗女性盆腔炎的临床及 基础研究进展[J]. 临床医学进展, 2026, 16(6): 459-467. https://doi.org/10.12677/acm.2026.1662240

参考文献

[1] 林业锦, 许小凤. 盆腔炎性疾病中医外治法运用现状[J]. 中医药临床杂志, 2022, 34(10): 1037-1041.
[2] 刘太容, 罗碧如, 秦尔奇, 等. 盆腔炎性疾病中医外治法研究进展[J]. 按摩与康复医学, 2019, 10(17): 50-53.
[3] 王春环, 李维民, 刘秀云, 等. 中医外治法在慢性盆腔炎中的应用研究进展[J]. 江苏中医药, 2016, 48(2): 83-85.
[4] 中国中西医结合学会妇产科专业委员会. 女性盆腔炎性疾病中西医结合诊治指南[J]. 世界中西医结合杂志, 2024, 19(3): 618-626, 636.
[5] 农秀明, 黄小丽. 中医外治法在慢性盆腔炎治疗中的应用研究进展[J]. 广西中医药, 2024, 47(3): 67-70.
[6] 高燕申, 陈旦平. 中医外治慢性盆腔炎的应用[J]. 中国中医药现代远程教育, 2022, 20(22): 200-204.
[7] 马力凤, 龚燕岚. 盆腔炎病人中药保留灌肠时间和插管深度研究进展[J]. 护理研究, 2018, 32(24): 3829-3830.
[8] 严如根, 何静, 薛哗佳, 等. 中药灌肠方治疗盆腔炎性疾病后遗症的用药规律研究[J]. 中成药, 2024, 46(10): 3492-3496.
[9] 李欢. 中药保留灌肠辅助治疗盆腔炎性疾病湿毒壅盛证临床观察[J]. 西部中医药, 2024, 37(12): 150-152.
[10] 王新霞, 黄秋阳, 龚杏姿. 加味红藤败酱汤联合西药治疗湿热瘀阻型慢性盆腔炎临床研究[J]. 新中医, 2023, 55(10): 68-74.
[11] 田华, 周建惠, 尹晓燕, 等. 蒲楝清化汤内服联合中药保留灌肠治疗湿热瘀结型盆腔炎性疾病后遗慢性盆腔痛的效果[J]. 妇儿健康导刊, 2025, 4(2): 30-33, 38.
[12] 朱丹. 中医三联疗法治疗盆腔炎性疾病湿热瘀结型临床观察[J]. 黔南民族医专学报, 2025, 38(2): 178-181.
[13] 晏清, 周颖. 中药灌肠方联合雷火灸治疗慢性盆腔炎的效果及对炎症因子的影响[J]. 医学信息, 2024, 37(11): 116-119.
[14] 吴周汉, 唐梅文, 许永辉, 等. 灸法联合中药保留灌肠治疗盆腔炎性疾病后遗症的疗效分析——一项Meta分析[J]. 浙江中西医结合杂志, 2025, 35(3): 275-280.
[15] 李龙欣, 贾会平, 孙建玲. 自拟中药方内服、中药灌肠、微波治疗联合常规西药治疗慢性盆腔炎的效果分析[J]. 中国社区医师, 2024, 40(18): 83-85.
[16] 陈婕妤, 盛莉莉, 陈俭, 等. 中药热熨联合中药灌肠治疗慢性盆腔炎(气滞血瘀型)的临床价值及对患者情绪的影响[J]. 山西医药杂志, 2023, 52(4): 243-246.
[17] 热汗古力·开买尔江, 海热古力·阿不力米提. 辨证保留灌肠结合中药塌渍治疗慢性盆腔炎119例[J]. 中国中医药现代远程教育, 2014, 12(12): 136-136, 139.
[18] 赵雅萍. 中药直肠给药的研究动态[J]. 中草药, 1998, 29(1): 51-54.
[19] 杨鑫宝, 杨秀伟, 刘建勋. 延胡索物质基础研究[J]. 中国中药杂志, 2014, 39(1): 20-27.
[20] 王春, 魏伟, 杨昭毅, 等. 芍药苷微乳溶液在大鼠在体肠的吸收动力学研究[J]. 中国药理学通报, 2009, 25(2): 181-185.
[21] Song, L., Tian, L., Ma, Y., Xie, Y., Feng, H., Qin, F., et al. (2017) Protection of Flavonoids from Smilax china L. Rhizome on Phenol Mucilage-Induced Pelvic Inflammation in Rats by Attenuating Inflammation and Fibrosis. Journal of Functional Foods, 28, 194-204. [Google Scholar] [CrossRef
[22] 张宗敏, 杜鑫, 王军, 等. 红藤解毒灌肠方治疗慢性盆腔炎疗效及其对血清MCP-1、IL-1β、TGF-β1表达的影响[J]. 世界中西医结合杂志, 2021, 16(2): 372-375, 379.
[23] Ji, X., Hu, Q., Yang, C., Huang, L., Huang, Y., Deng, L., et al. (2024) Modified Hongteng Baijiang Decoction Enema Improves Sequelae of Pelvic Inflammatory Disease by Regulating the LIF/JAK2/STAT3 Pathway and Gut Microbiota. Immunity, Inflammation and Disease, 12, e1300. [Google Scholar] [CrossRef] [PubMed]
[24] 周娜, 徐桂冉, 陈洁, 等. 安盆清带方保留灌肠经肠道微生态调节机制对湿热瘀结型盆腔炎患者的治疗作用[J]. 世界中西医结合杂志, 2023, 18(11): 2292-2296, 2307.
[25] Zhang, Y., Zhao, Z., Chen, H., Fu, Y., Wang, W., Li, Q., et al. (2021) The Underlying Molecular Mechanisms Involved in Traditional Chinese Medicine Smilax china L. for the Treatment of Pelvic Inflammatory Disease. Evidence-Based Complementary and Alternative Medicine, 2021, 5552532. [Google Scholar] [CrossRef] [PubMed]
[26] 沈凡琪, 韩延华, 刘丽. 中医药治疗盆腔炎性疾病相关信号通路的研究进展[J]. 中国实验方剂学杂志, 2023, 29(18): 251-258.
[27] 武亚丽, 李宏睿, 马晓玲, 等. 多囊卵巢综合征和输卵管阻塞不孕症患者肠道菌群特征分析[J]. 海军军医大学学报, 2022, 43(12): 1378-1384.
[28] 陈燕, 李旭, 郝迪, 等. 消炎汤调节肠道微生态改善大鼠慢性盆腔炎的研究[J]. 现代药物与临床, 2020, 35(5): 849-853.
[29] Dong, Y., Yuan, Y., Ma, Y., Luo, Y., Zhou, W., Deng, X., et al. (2021) Combined Intestinal Metabolomics and Microbiota Analysis for Acute Endometritis Induced by Lipopolysaccharide in Mice. Frontiers in Cellular and Infection Microbiology, 11, Article 791373. [Google Scholar] [CrossRef] [PubMed]
[30] Hu, X., Mu, R., Xu, M., Yuan, X., Jiang, P., Guo, J., et al. (2020) Gut Microbiota Mediate the Protective Effects on Endometritis Induced by Staphylococcus aureus in Mice. Food & Function, 11, 3695-3705. [Google Scholar] [CrossRef] [PubMed]
[31] 张岩雪, 李红艳, 孙军华, 等. 基于PD-1/PD-L1信号通路探讨妇炎汤对慢性盆腔炎小鼠Treg/Th17免疫平衡的影响[J]. 中国优生与遗传杂志, 2022, 30(5): 744-749.
[32] Wang, K., Wang, K., Wang, J., Yu, F. and Ye, C. (2022) Protective Effect of Clostridium butyricum on Escherichia coli-Induced Endometritis in Mice via Ameliorating Endometrial Barrier and Inhibiting Inflammatory Response. Microbiology Spectrum, 10, e0328622. [Google Scholar] [CrossRef] [PubMed]
[33] 程友花, 唐小玲, 徐立军. 择时中药保留灌肠改善湿热瘀结型盆腔炎患者证候[J]. 护理学杂志, 2018, 33(11): 46-48.